• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES COMMANDER DS WITH SAPIEN 3; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES COMMANDER DS WITH SAPIEN 3; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED Back to Search Results
Model Number 9750CM26A
Device Problems Burst Container or Vessel (1074); Difficult to Remove (1528)
Patient Problem Vascular Dissection (3160)
Event Date 10/25/2023
Event Type  Injury  
Manufacturer Narrative
Investigation is ongoing.H3 other text : not returned.
 
Event Description
As reported by a field clinical specialist, a patient underwent a transfemoral tavr procedure with a 26mm sapien 3 ultra valve in aortic position.During inflation of the 26mm sapien 3 ultra valve, the commander balloon ruptured.The balloon was fully inflated during the balloon rupture.The balloon was then retracted into the esheath.At the access site, there was significant resistance and the device could not be removed from the body.Manual compression of the artery was performed and vascular surgery was called to perform a cut down.Following the cut down, the device was removed.It appeared that the balloon did not rupture longitudinally.The "bunching" of the balloon material was causing the increased resistance to remove the device.It is hypothesized that the balloon ruptured due to the heavy calcification of the stj per the implanting physician.Following successful cut down on the rt.Femoral artery, there was a dissection noted in the distal external illiac.The surgeon and implanter agreed to not intervene at this time.
 
Manufacturer Narrative
The device was not returned to edwards lifesciences for evaluation.A review of edwards lifesciences risk management documentation was performed for this case.The reported event is an anticipated risk of the transcatheter heart valve procedure, additional assessment of this event is not required at this time.Balloon burst: the complaint for "balloon burst" was unable to be confirmed due to lack of device return or applicable imagery.Available information suggests calcification likely contributed to the event as the customer reported that "it is hypothesized that the balloon ruptured due to the heavy calcification of the stj per the implanting physician." the presence of calcification can create a challenging anatomy for balloon inflation.While the balloons are sufficiently designed and tested to ensure the burst pressure is at or above the rated burst pressure, calcified nodules can compromise the structure of the balloon wall via following mechanisms such as puncture, local overstretching, open cell impingement, or stress concentration.Difficulty or inability to withdraw system through vasculature: the complaint for "difficulty or inability to withdraw system through vasculature" was unable to be confirmed due to lack of device return or applicable imagery.Available information suggests that withdrawal of burst balloon likely contributed to the event as the customer reported that "there was significant resistance, and the device could not be removed from the body." the customer also stated that -the "bunching" of the balloon material was causing the increased resistance to remove the device." as the balloon was burst, the altered balloon profile could have made it more susceptible to catch on patient vasculature which would have then led to the experienced retrieval difficulty.Complaint histories for all reported events are reviewed against trending control limits monthly, and any excursions above the control limits are assessed and documented as part of this monthly review.As such, neither a product risk assessment, nor corrective or preventative actions are required at this time.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COMMANDER DS WITH SAPIEN 3
Type of Device
AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED
Manufacturer (Section D)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer (Section G)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer Contact
renee van dorne
1 edwards way
irvine, CA 92614
9492506385
MDR Report Key18167448
MDR Text Key328478431
Report Number2015691-2023-17606
Device Sequence Number1
Product Code NPT
UDI-Device Identifier00690103207835
UDI-Public(01)00690103207835(17)250628(10)65182775
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P140031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 01/06/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/19/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number9750CM26A
Device Lot Number65182775
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received12/18/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/29/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient SexFemale
-
-